November was a busy month for the HealthTech Activator (HTA), with several successful online events delivered across regulatory, reimbursement, and market validation topics. Our first 2022 events are now available for signup. Details are below along with other HTA updates and insights.
We’d also love to hear about your experience using data to validate your market and how our database support offering could help. If you have three minutes to spare, we’d be grateful if you could complete this short survey to tell us more about your journey and needs. Thank you to those who completed it last month.
HTA Events
An Introduction to Knowing your Customer and your Market (online)
15-16 February 2022
This popular market validation workshop focuses on helping you know your customer and your market. It will be kicking off again in February 2022.
The workshop is aimed at early stage healthtech businesses, or businesses that would like to have a fresh look at their customers and market, and how they have validated them to date. The November event was sold out so be sure to register early to reserve your spot.
Presented by Tim McCready of BioPacific Partners, this programme is tailored for the specific capital raising challenges faced by healthtech businesses. This workshop is planned as an in-person event in Auckland, but will move online if required.
We encourage those early to mid-stage healthtech companies seeking to raise capital for the first time outside their immediate contacts to attend.
Innovation Across the Value-chain: Broadening your 'customers' for sustainable sales
Dan Hansen, Apagie
Dan Hansen from Apagie discusses the importance of identifying customers throughout the healthcare value-chain who collectively drive innovation adoption. Once identified, understanding those customers and their problems is critical for securing sustainable sales.
HTA website updates continue, including improved Market Validation and Reimbursement pages that provide a better overview of HTA offerings and links to other resources. Let us know what you think.
BioCell has developed a platform for producing high-quality mRNA at scale in NZ, enabling better local access for vaccine research and other RNA-based projects.
Orbis Diagnostics’ immune response testing product, the Arca, continues through trials with the aim to help individuals know when a booster vaccine might be necessary.
After securing a total of $1.75m in seed funding, Webtools Health have spun off their connected care platform, Centrik, as it goes live with The Better Health Group.
.jpg?upscale=true&width=130&upscale=true&name=Apagie%20logo%20(December%202020).jpg)
